PharmaTher (THRM)...Should acquire PharmaDrug!!! Only makes sense, as PharmaTher owns 49% of their subsidiary Sairiyo who owns the patent to that PD-001 approved for Clinical Trial. Market Cap only $1.5 million for ThermaDrug. That convertible debenture issued/renewed recently alone has a conversion price of .05 cents/share. PharmaDrugs other 100% subsidiary SecureDose has significate value as well. Only makes sense that a merge take place here, ThermaTher has publically stated in their new releases their plans to take SAIRIYO public in the very near future. That speaks volume and can only be attained and be mutually beneficial for all shareholders on both sides thru a possible merger with ThermaTher and certainly bring much higher valuation for PharmaDrug shareholders. Win..Win for both companies here and especially PharmaDrug inverstors at these rock bottom lows. Just my opinion..these collaborations at the beginnings mostly lead to eventual mergers/acquititions. PharmaDrug extremely under valued in my opinion. Time will tell.